Key result
Concomitant PFA and WATCHMAN FLX achieves complete LAA seal and sinus rhythm at 6 months.
Why the study?
Pulsed field ablation is a novel non-thermal method for pulmonary vein isolation in AF, and concomitant left atrial appendage closure might be beneficial for high-stroke-risk patients ineligible for oral anticoagulation.
Case Report (n=1)
No
Concomitant pulsed field ablation PVI and WATCHMAN FLX left atrial appendage closure via a single venous access is feasible and safe, provided LAA landing zone sizing is performed prior to PVI to avoid undersizing from post-ablation ridge oedema.
Answers are grounded in this paper and cite their sources.
Single-case feasibility of single-access PFA PVI plus WATCHMAN FLX supports further exploration; leaves open confirmation of safety and efficacy in prospective trials.
Background: Pulsed field ablation (PFA) is a novel non-thermal cardiac ablation method utilizing irreversible electroporation which has been introduced especially for treatment of atrial fibrillation (AF) by pulmonary vein isolation (PVI). Interventional left atrial appendage closure (LAAC) is an alternative to oral anticoagulation (OAC) in patients with non-valvular AF and high stroke risk who are ineligible for OAC. A concomitant PVI and LAAC might be beneficial for patients. Case summary: VA Score of 4 and HASBLED Score of 3 due to previous gastrointestinal bleeding were scheduled for a concomitant PVI + LAAC procedure. For minimum risk, a streamlined approach utilizing a single femoral vein puncture in combination with a suture-based closure system (Perclose Prostyle, Abbott) was performed. The transoesophageal echocardiography (TOE) LAA landing zone measurements were achieved directly prior ablation. Pulmonary vein isolation was performed with pentaspline PFA catheter (FARAPULSE). Although a swelling of the left atrial ridge was observed, a 24 mm WATCHMAN FLX device was successfully implanted. The patient was mobilized after 2 h and discharged on the next day. After 2 months on OAC, TOE found no gaps or leakage of the LAAC device and OAC was switched to acetylsalicylic acid monotherapy. Discussion: A streamlined concomitant PFA-based PVI and LAAC procedure utilizing FARAPULSE and WATCHMAN FLX devices seems to be feasible and safe. Swelling of the ridge after PVI was observed; however, the sizing measurements have been performed prior PVI, and the LAAC procedure was successful with no evidence for gaps or leakage. A concomitant approach might be a suitable option for selected patients.
No takes yet. Share an insight, caveat, or question.
Heeger et al. (2025) conducted a case report in Symptomatic persistent atrial fibrillation with high stroke and bleeding risk (n=1). Concomitant pulsed field ablation-based pulmonary vein isolation (FARAPULSE) and left atrial appendage closure (24 mm WATCHMAN FLX) via single femoral venous access was evaluated on Procedural feasibility, complete left atrial appendage seal on transoesophageal echocardiography at 2 months, and freedom from stroke, bleeding, or arrhythmia recurrence at 6 months. Concomitant pulsed field ablation PVI and WATCHMAN FLX LAA closure in 1 patient achieved complete LAA seal at 2 months and stable sinus rhythm without stroke or bleeding at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: